Physician Portal

Physician Stories

Promising results from LEAD clinical trial for 2RT® in preventing progression of early AMD

Professor Robyn Guymer AM, MBBS, PhD, FRANZCO, FAAHMS, the Principal Investigator for the Laser Intervention for Early AMD (LEAD) clinical trial, shares promising results for the implementation of 2RT® to prevent AMD progression. Professor Guymer highlights the importance of the world-first study in determining the role of 2RT® in the AMD treatment paradigm.

2RT® in the Fundamental Research Program of the LEAD clinical trial

Professor Erica Fletcher, PhD, Leader of the Fundamental Research Program in the Laser Intervention for Early AMD (LEAD) clinical trial, explains how the 2RT® unique mechanism of action may remove the early signs of age-related macular degeneration. Professor Fletcher highlights the distinctive differences that set 2RT® apart from current conventional retinal lasers.

2RT® Retinal Rejuvenation - Video interview with John Marshall PhD, FRCPath, FMedSci (UK)

At the Inaugural European Laser Innovations Forum in Nice, Prof. John Marshall discussed the evolution of 2RT® Retinal Rejuvenation Therapy as an intervention for early AMD – and how 2RT®  technology compares to other laser-based retinal treatments.

2RT® in Clinical Practice Video - interview with Andrea Cusumano MD, PhD (Italy)

Ellex sat down with Prof. Andrea Cusumano at the inaugural European Laser Innovations Forum in Nice to discuss the role of 2RT® in clinical practice.

This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More